Tendonitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Therapy (Therapy v/s Surgery), By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others), By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationTendonitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Therapy (Therapy v/s Surgery), By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Others), By Region and Competition
Increased Number of Sport-Related Injuries
Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University.
Growing Aging Population
According to the National Safety Council (NSC), in 2021 exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.
Market Segmentation
As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S.
Market Players
Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.
Recent Development
Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · By Therapy · By Condition · By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key companies profiled | Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy